2021
DOI: 10.1007/s00281-021-00869-6
|View full text |Cite
|
Sign up to set email alerts
|

Role of bile acids in inflammatory liver diseases

Abstract: Bile acids and their signaling pathways are increasingly recognized as potential therapeutic targets for cholestatic and metabolic liver diseases. This review summarizes new insights in bile acid physiology, focusing on regulatory roles of bile acids in the control of immune regulation and on effects of pharmacological modulators of bile acid signaling pathways in human liver disease. Recent mouse studies have highlighted the importance of the interactions between bile acids and gut microbiome. Interfering wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
51
0
6

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 68 publications
(57 citation statements)
references
References 108 publications
0
51
0
6
Order By: Relevance
“…Changes in bile acid and oxysterol levels contribute and/or occur during the establishment of metabolic abnormalities such as type 2 diabetes and MAFLD [19,38]. Therefore, unravelling the contribution of specific cytochrome P450 superfamily enzymes that mediate their biosynthetic pathways can shed light on their pathophysiological role.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Changes in bile acid and oxysterol levels contribute and/or occur during the establishment of metabolic abnormalities such as type 2 diabetes and MAFLD [19,38]. Therefore, unravelling the contribution of specific cytochrome P450 superfamily enzymes that mediate their biosynthetic pathways can shed light on their pathophysiological role.…”
Section: Discussionmentioning
confidence: 99%
“…Next to nuclear receptors, G protein-coupled bile acid receptors (such as TGR5) regulate immune cells in various organs. For instance, the TGR5 ligand LCA reduces pro-inflammatory signaling pathways in macrophages of the liver [19]. Notably, CYP7B1 influences concentrations of hydroxycholesterol and bile acid species, suggesting that the enzyme could affect immune cell abundance and plasticity in chronic inflammatory metabolic disorders such as NASH.…”
Section: Introductionmentioning
confidence: 99%
“…The ratio of these two primary bile acids is regulated by the sterol 12a-hydroxylase (CYP8B1), which is necessary for CA synthesis [62]. To enhance solubility, the newly synthesized bile acids are conjugated with hydrophilic molecules, such as taurine or glycine [63]. SLC6A9 and SLC6A6 genes encode a multi-pass membrane protein that transports glycine or taurine, respectively [64,65].…”
Section: Discussionmentioning
confidence: 99%
“…BA receptors became focus of interest for drug targets in cholestatic diseases. Especially, Farnesoid X receptor (FXR) as a nuclear receptor, and Takeda G protein coupled receptor 5 (TGR5) as a membrane bound receptor are extensively investigated [43]. It is possible that bile acids trigger ROS production and inflammasome activation after binding to FXR or TGR5 [44].…”
Section: Discussionmentioning
confidence: 99%